Related Experiment Videos
Erythema ab igne: new technology rebounding upon its users?
Fernanda Salgado1, Marc Z Handler1, Robert A Schwartz1
1Dermatology and Pathology, Rutgers New Jersey Medical School, Rutgers University School of Public Affairs and Administration, Newark, NJ, USA.
International Journal of Dermatology
|April 4, 2017
Summary
Erythema ab igne (EAI) is a chronic skin condition caused by prolonged infrared heat exposure. Modern sources like laptops may increase EAI cases, potentially indicating underlying disorders or cancers.
Area of Science:
- Dermatology
- Medical Research
Background:
- Erythema ab igne (EAI) is a chronic skin condition from prolonged infrared radiation exposure.
- Historically linked to traditional heat sources, modern devices like laptops and heating pads are now recognized as potential causes.
- Changes in EAI epidemiology include a potential increase in younger patients.
Purpose of the Study:
- To review the causes, clinical presentation, and potential underlying conditions associated with Erythema ab igne.
- To discuss the evolving epidemiology and modern sources of infrared radiation exposure.
- To outline the prognosis and management strategies for EAI, including premalignant changes and rare associated cancers.
Main Methods:
- Literature review of Erythema ab igne cases and associated factors.
- Analysis of clinical presentations and epidemiological trends.
- Review of treatment modalities and long-term outcomes.
Main Results:
- EAI is caused by prolonged exposure to infrared radiation from both traditional and modern heat sources.
- Localized EAI can signal underlying medical conditions, including malignancies.
- While prognosis is generally good with heat source removal, chronic cases may require further treatment for dysplasia or associated cancers.
Conclusions:
- Erythema ab igne is re-emerging due to modern heat sources, affecting potentially younger demographics.
- Prompt identification and removal of the heat source are crucial for EAI management.
- Awareness of EAI's potential as a marker for serious underlying pathology is essential for clinical practice.